• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunosuppression in hematological cancer patients with Covid-19 -Uncomplicated infections but delayed viral clearance?

作者信息

Boyd Karen, Parcell Benjamin, Tauro Sudhir

机构信息

Department of Haematology, Ninewells Hospital and School of Medicine, Dundee, DD1 9SY, Scotland, United Kingdom.

Department of Medical Microbiology, Ninewells Hospital and School of Medicine, Dundee DD1 9SY, Scotland, United Kingdom.

出版信息

Leuk Res. 2020 Sep;96:106407. doi: 10.1016/j.leukres.2020.106407. Epub 2020 Jun 30.

DOI:10.1016/j.leukres.2020.106407
PMID:32652329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7326457/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6594/7326457/1b96e4471158/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6594/7326457/1b96e4471158/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6594/7326457/1b96e4471158/gr1_lrg.jpg

相似文献

1
Immunosuppression in hematological cancer patients with Covid-19 -Uncomplicated infections but delayed viral clearance?新冠肺炎血液系统癌症患者的免疫抑制——感染不复杂但病毒清除延迟？
Leuk Res. 2020 Sep;96:106407. doi: 10.1016/j.leukres.2020.106407. Epub 2020 Jun 30.
2
Using "old" medications to fight new COVID-19: Re-purposing with a purpose.使用“旧”药物对抗新型冠状病毒肺炎：有目的地重新利用
J Mol Cell Cardiol. 2020 Sep;146:41-42. doi: 10.1016/j.yjmcc.2020.07.005. Epub 2020 Jul 18.
3
Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.曾接触过免疫检查点抑制剂的癌症患者感染2019冠状病毒病（COVID-19）的临床结局
Cancer Commun (Lond). 2020 Aug;40(8):374-379. doi: 10.1002/cac2.12077. Epub 2020 Jul 15.
4
Hypertension and SARS-CoV-2 infection: is inflammation the missing link?高血压与2019冠状病毒病感染：炎症是其中的缺失环节吗？
Cardiovasc Res. 2020 Nov 1;116(13):e193-e194. doi: 10.1093/cvr/cvaa273.
5
Hydroxychloroquine in Covid-19: Does the end justify the means?新冠疫情中使用羟氯喹：结果能证明手段合理吗？
Curr Res Transl Med. 2020 Aug;68(3):81-82. doi: 10.1016/j.retram.2020.04.002. Epub 2020 Apr 18.
6
Silencing of immune activation with methotrexate in patients with COVID-19.使用甲氨蝶呤使新冠肺炎患者的免疫激活沉默。
J Neurol Sci. 2020 Aug 15;415:116942. doi: 10.1016/j.jns.2020.116942. Epub 2020 May 25.
7
Surviving COVID-19: A disease tolerance perspective.从疾病耐受性角度看新冠病毒感染后的生存情况
Sci Adv. 2020 Apr 29;6(18):eabc1518. doi: 10.1126/sciadv.abc1518. eCollection 2020 May.
8
Thrombus in the right atrium after COVID-19 pneumonia.新型冠状病毒肺炎后右心房血栓形成。
Rev Esp Cardiol (Engl Ed). 2020 Oct;73(10):845. doi: 10.1016/j.rec.2020.06.023. Epub 2020 Jul 17.
9
How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.新冠病毒是如何致人死亡的？不确定性正阻碍医生选择治疗方法的能力。
Nature. 2020 Apr;580(7803):311-312. doi: 10.1038/d41586-020-01056-7.
10
SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report.一名出院的新冠肺炎患者的严重急性呼吸综合征冠状病毒2阳性：病例报告
Clin Microbiol Infect. 2020 Aug;26(8):1115-1117. doi: 10.1016/j.cmi.2020.04.032. Epub 2020 Apr 29.

引用本文的文献

1
Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.某癌症中心2019冠状病毒病的临床、病毒学特征及转归
Open Forum Infect Dis. 2021 Apr 16;8(6):ofab193. doi: 10.1093/ofid/ofab193. eCollection 2021 Jun.

本文引用的文献

1
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.2019冠状病毒病（COVID-19）时代成人急性白血病和髓系肿瘤患者管理的特殊考量：国际专家小组的建议
Lancet Haematol. 2020 Aug;7(8):e601-e612. doi: 10.1016/S2352-3026(20)30205-2. Epub 2020 Jun 18.
2
Response to "COVID-19 in persons with haematological cancers".对“血液系统癌症患者中的COVID-19”的回应
Leukemia. 2020 Aug;34(8):2265-2270. doi: 10.1038/s41375-020-0914-x. Epub 2020 Jun 11.
3
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
接受化疗或其他抗癌治疗的癌症患者的 COVID-19 死亡率：一项前瞻性队列研究。
Lancet. 2020 Jun 20;395(10241):1919-1926. doi: 10.1016/S0140-6736(20)31173-9. Epub 2020 May 28.
4
Reply to "COVID-19 in persons with haematological cancers": a focus on myeloid neoplasms and risk factors for mortality.对“血液系统恶性肿瘤患者中的 COVID-19”的回复：聚焦于髓系肿瘤及死亡风险因素
Leukemia. 2020 Jul;34(7):1957-1960. doi: 10.1038/s41375-020-0877-y. Epub 2020 May 26.
5
RT-PCR for SARS-CoV-2: quantitative versus qualitative.新型冠状病毒2019（SARS-CoV-2）的逆转录聚合酶链反应（RT-PCR）：定量与定性
Lancet Infect Dis. 2021 Feb;21(2):165. doi: 10.1016/S1473-3099(20)30424-2. Epub 2020 May 20.
6
Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.血液肿瘤患者中2019冠状病毒病的临床结局
Br J Haematol. 2020 Jul;190(2):e64-e67. doi: 10.1111/bjh.16852. Epub 2020 Jun 10.
7
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System.纽约医院系统中 COVID-19 癌症患者的病死率。
Cancer Discov. 2020 Jul;10(7):935-941. doi: 10.1158/2159-8290.CD-20-0516. Epub 2020 May 1.
8
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.免疫介导性炎症疾病中的新冠病毒病——来自纽约的病例系列
N Engl J Med. 2020 Jul 2;383(1):85-88. doi: 10.1056/NEJMc2009567. Epub 2020 Apr 29.
9
COVID-19 in persons with haematological cancers.COVID-19 与血液系统恶性肿瘤。
Leukemia. 2020 Jun;34(6):1637-1645. doi: 10.1038/s41375-020-0836-7. Epub 2020 Apr 24.
10
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.冠状病毒与免疫抑制患者：第三次疫情期间的实际情况
Liver Transpl. 2020 Jun;26(6):832-834. doi: 10.1002/lt.25756. Epub 2020 Apr 24.